Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02831816 · ClinicalTrials.gov registry record · Phase 3
Clinical Evaluation of Patient Preoperative Prep
A Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 640
- Enrollment target
- 1
- Study location
NCT02831816: Completed Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.
NCT02831816 is a Phase 3 study of Surgical Skin Preparation that has completed, run by Zurex Pharma. The registered enrollment target is 640 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02831816, a Phase 3 study of Surgical Skin Preparation, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 640 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.
Primary Outcome
A a 3-log per cm2 bacterial reduction on the inguinal region is considered a success.
Conditions Studied
Interventions
- DRUG ZuraPrep
- DRUG ChloraPrep
- DRUG ZP Vehicle
Study Locations (1)
Montana
- BioScience Laboratories, Inc. - Bozeman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2016-08-03 |
| Est. Completion | 2017-08-03 |
| Phase | Phase 3 |
What the finished NCT02831816 record still lists
NCT02831816 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Surgical Skin Preparation appearing as the primary indexed condition, and to 3 interventions - of which ZuraPrep is the first listed.
NCT02831816 reports a single indexed study location in Montana.
Frequently Asked Questions
What is clinical trial NCT02831816 about?
NCT02831816 is a clinical study titled "Clinical Evaluation of Patient Preoperative Prep". The objective of the study is to demonstrate the antimicrobial efficacy of the ZP Preoperative Prep on skin flora of the abdomen and inguinal regions of human subjects.
What is the current status of trial NCT02831816?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 640 participants. The study started on 2016-08-03. Estimated completion is 2017-08-03.
What conditions does trial NCT02831816 study?
This clinical trial studies the following conditions: Surgical Skin Preparation.
What interventions are being tested in trial NCT02831816?
The interventions under investigation include: ZuraPrep (DRUG), ChloraPrep (DRUG), ZP Vehicle (DRUG).
Who is sponsoring clinical trial NCT02831816?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02831816 being conducted?
This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Skin Preparation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02831816's enrollment target sits among peer trials
640 576th of 2000 higher than 1,422 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI